Inhibition of Cholesterol Biosynthesis Modulates Epithelial-Mesenchymal Transition in Primary Cicatricial Alopecia Through TGFβ and Angiotensin Receptors

    Leemon Nikhila, Suresh Senan, Shahul Hameed Najeeb, T. M. Binumon, Parameswara Panicker Sreejith
    Image of study
    TLDR Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.
    The study investigates the role of cholesterol biosynthesis inhibition in Primary Cicatricial Alopecia (PCA), a hair loss condition. Researchers used small interfering RNAs (siRNA) of TGFβ, AGTR, and their regulators to study the modulation of Epithelial Mesenchymal Transition (EMT), a process potentially affected by PCA. Findings suggest that reduced cholesterol production leads to permanent hair follicle damage in PCA patients. The study also found that PPARγ, AhR, and AGTR can act as vital EMT regulators. The study concludes that EMT in hair loss can be regulated by suppressing cholesterol biosynthesis, suggesting cholesterol and EMT modulators as potential inhibitors in PCA etiology.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 289 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  119 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Similar Research

    5 / 1000+ results